BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37768813)

  • 21. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.
    Liu X; Sun K; Yang H; Xia L; Lu K; Meng X; Li Y
    BMC Cancer; 2023 Apr; 23(1):361. PubMed ID: 37081431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors.
    Liu YF; Liu JE; Zhu Y; Mak YW; Qiu H; Liu LH; Yang SS; Chen SH
    Support Care Cancer; 2021 Sep; 29(9):5435-5445. PubMed ID: 33704565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
    Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
    J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
    Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
    Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
    Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution.
    Yuan Q; Hou J; Zhou R; Liao Y; Zheng L; Jiao C; Zhou W; Wu G
    Ann Surg Oncol; 2021 Nov; 28(12):7319-7328. PubMed ID: 33891201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a risk prediction model for breast cancer-related lymphedema in postoperative patients with breast cancer.
    Li MM; Wu PP; Qiang WM; Li JQ; Zhu MY; Yang XL; Wang Y
    Eur J Oncol Nurs; 2023 Apr; 63():102258. PubMed ID: 36821887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA; Peng J; He Y; Chen J; Cen Y
    Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
    Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
    Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
    Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
    Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.
    Gennaro M; Maccauro M; Mariani L; Listorti C; Sigari C; De Vivo A; Chisari M; Maugeri I; Lorenzoni A; Aliberti G; Scaperrotta GP; Caraceni A; Pruneri G; Folli S
    Cancer; 2022 Dec; 128(24):4185-4193. PubMed ID: 36259883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight Gain and Lymphedema After Breast Cancer Treatment: Avoiding the Catch-22?
    Boyages J; Cave AE; Naidoo D; Ee CCL
    Lymphat Res Biol; 2022 Aug; 20(4):409-416. PubMed ID: 34748426
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
    Farley CR; Irwin S; Adesoye T; Sun SX; DeSnyder SM; Lucci A; Shaitelman SF; Chang EI; Ueno NT; Woodward WA; Teshome M
    Ann Surg Oncol; 2022 Oct; 29(10):6370-6378. PubMed ID: 35854031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Breast Cancer-Related Lymphedema: An Umbrella Review.
    Shen A; Qiang W; Zhang L; Bian J; Zhu F; Zhang Z; Lu Q
    Ann Surg Oncol; 2024 Jan; 31(1):284-302. PubMed ID: 37725224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
    Jørgensen MG; Gözeri E; Petersen TG; Sørensen JA
    Clin Breast Cancer; 2023 Jul; 23(5):e296-e304.e2. PubMed ID: 37095025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.